A cutting-edge base-edited CAR T-cell therapy is opening a revolutionary new frontier for patients battling aggressive T-cell leukemia.
A single-dose gene replacement therapy is found to improve movement ability in children over 2 years of age and teenagers ...
Vertex Pharmaceuticals presents clinical data demonstrating benefits of Casgevy in SCD and TDT patients aged 5+ at ASH ...
On a video call in early September, Sarah Tabrizi first saw the data that she and other researchers studying Huntington’s ...
This sponsored article was provided by a partner and is not editorial content from Los Angeles Magazine or the Engine Vision Media Network. Every cell in your body holds a unique genetic code within ...
Four decades have passed since cochlear implants gave infants born deaf the ability to hear. Now, gene therapy promises to ...
Vertex Pharmaceuticals said on Saturday its gene therapy helped children aged between 5 and 11 years with sickle cell disease ...
The chief medical officer of Genetix Biotherapeutics, formerly known as Bluebird bio, discusses timelines and operational ...
Three years after introducing Hemgenix, the first gene therapy for hemophilia B, CSL Behring has released long-term data ...
Preliminary results from two trials of the gene therapy exagamglogene autotemcel (exa-cel) suggest the therapy offers an ...
Pharmaceutical Technology on MSN
In a Honduran city, biotechs create gene therapy cocktails to fight aging
Biotechs in the charter city of Próspera aim to cure aging, but experts question the feasibility of their goals.
In medicine these days, the word "gene" shows up in all sorts of different contexts and conjugations. There's genetics, of course, and there's genomics. Then there's meta-genomics -- and don't forget ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback